Kiniksa Pharmaceuticals International (KNSA) Selling, General & Administrative (2017 - 2026)
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 210.97 Bn | 196.98 Bn | 7.24 Bn | 1.75 Bn |
| 2 | Gilead Sciences | 180.98 Bn | 177.80 Bn | 6.22 Bn | 1.92 Bn |
| 3 | Vertex Pharmaceuticals | 132.09 Bn | 124.24 Bn | 2.84 Bn | 582.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.57 Bn | 3.93 Bn | 662.10 Mn |
| 5 | Argenx Se | 61.71 Bn | 56.53 Bn | 1.37 Bn | -417.00 Mn |
| 6 | Moderna | 54.60 Bn | 49.46 Bn | 52.00 Mn | 216.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.02 Bn | 30.71 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | 709.70 Mn |
| 9 | Roivant Sciences | 29.76 Bn | 29.76 Bn | 1.16 Mn | 165.53 Mn |
| 10 | Kiniksa Pharmaceuticals International | 6.15 Bn | 5.62 Bn | 220.03 Mn | 63.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.87 Mn |
| Mar 31, 2026 | 61.15 Mn |
| Dec 31, 2025 | 56.78 Mn |
| Sep 30, 2025 | 49.10 Mn |
| Jun 30, 2025 | 46.86 Mn |
| Mar 31, 2025 | 43.53 Mn |
| Dec 31, 2024 | 40.54 Mn |
| Sep 30, 2024 | 46.40 Mn |
| Jun 30, 2024 | 42.40 Mn |
| Mar 31, 2024 | 38.68 Mn |
| Dec 31, 2023 | 36.74 Mn |
| Sep 30, 2023 | 34.47 Mn |
| Jun 30, 2023 | 29.18 Mn |
| Mar 31, 2023 | 29.05 Mn |
| Dec 31, 2022 | 27.22 Mn |
| Sep 30, 2022 | 24.68 Mn |
| Jun 30, 2022 | 23.84 Mn |
| Mar 31, 2022 | 22.22 Mn |
| Dec 31, 2021 | 22.74 Mn |
| Sep 30, 2021 | 20.76 Mn |